For Immediate Release
Chicago, IL – January 11, 2012 – Zacks.com announces the list of
stocks featured in the Analyst Blog. Every day the Zacks Equity
Research analysts discuss the latest news and events impacting
stocks and the financial markets. Stocks recently featured in the
blog include UnitedHealth Group
Inc. ( UNH), Aetna Inc. ( AET),
WellPoint Inc. ( WLP), CIGNA
Corp. ( CI) and Wright Medical Group (
WMGI).
Get the most recent insight from Zacks Equity Research with the
free Profit from the Pros newsletter:
http://at.zacks.com/?id=5513
Here are highlights from Tuesday’s Analyst
Blog:
UNH Ends 2011 Better than Expected
UnitedHealth Group Inc. ( UNH) managed to
perform quite well in 2011, in contrast to analyst predictions that
the stock might be under pressure, given the challenges posed by
the HealthCare law and pressure on its government programs like
Medicare and Medicaid.
The stock of the biggest insurer (on the basis of revenue)
gained 38% in 2011 compared with 15% in 2010, a year in which
Health Care Reform was signed into law and 13% in 2009, the year
which saw heated debates over the Health Care reform.
UnitedHealth also managed to perform well versus its peers
Aetna Inc. ( AET), WellPoint Inc.
( WLP), CIGNA Corp. ( CI), which saw surges of
37%, 16% and 11%, respectively, in 2011.
Considering that new provisions relating to unreasonable premium
increases, adherence to minimum medical loss ratios (“MLR”) and
denying coverage to pre-existing diseases would pressurize its
earnings, UnitedHealth spent $4.9 million in 2009, on lobbying
against the reform. It spent $2.5 million in 2010 and $2.2 million
in 2011 to try and water down the reforms.
The law's impact on UnitedHealth’s business model and operating
fundamentals turned out to be quite manageable, albeit still
subject to uncertainty. The mandate regarding minimum MLR that went
into effect at the start of 2011 did not have a major effect on the
company’s bottom line.
UnitedHealth was also able to post better-than-expected results
throughout 2011, attributable to low medical claim costs, as
Americans delayed doctor visits and medical procedures in the face
of a weak economy.
In order to position itself for long-term growth, given the
Health Care Reform challenges, UnitedHealth continued to focus on
shifting more of its earnings to faster growing and less regulated
health-related service (non-insurance) businesses, with the goal of
ultimately making 30%-40% of operating income, up from about 20%
currently.
It believes that demand for consulting services, data
management, information technology and related infrastructure
development, disease management, and population-based health and
wellness programs will continue to grow. It also continues to
focus on Medicaid/state program business, highlighting the
significant upcoming opportunities and capabilities that a
diversified carrier could offer to state governments looking to
move the program to managed care.
UnitedHealth expects its 2012 EPS to be in the range of
$4.55-$4.75 and revenues in the $107.0 billion-$108.0 billion
range, up approximately 6.5% from the 2011 revenue guidance of more
than $101 billion. We expect the company to easily achieve the
targets based on its strong operating fundamentals. In fact,
UnitedHealth has had a tradition of guiding conservatively and then
beating the estimates to surprise investors.
Some of the factors that would boost UnitedHealth earnings
in 2012 are:
Medicare, Medicaid Gains: UnitedHealth enjoys a
high exposure in the Medicare market, which is expected to boom in
the coming years as millions of Americans will enter the retirement
age. Moreover, with the acquisition of XLHealth, the company will
further strengthen its position in the Medicare Advantage market,
compelling long-term growth.
Fast-growing Health Services segment: This
business, branded under the name Optum, boasts of higher margin and
is a very important part of the company’s diversification strategy.
For the nine months ended September 30, 2011, the segment delivered
approximately 18% growth. Now with the expansion of the health
service business, management expects the revenue contribution to
approximately double over time.
Strong balance sheet: The insurer enjoys a
solid balance sheet with adequate financial flexibility and a
favorable debt ratio, which helps it take decisions on acquisitions
easily. Moreover, UnitedHealth has opted for shareholder-friendly
measures for managing capital such as dividend payment and share
buybacks.
UnitedHealth currently retains a Zacks #3 Rank, which
translates into a short-term Hold rating. However, considering the
fundamentals, we are maintaining our long-term Outperform
recommendation on the shares.
Wright Launches New Products
International orthopedic devices company Wright
Medical Group ( WMGI) revealed the release of its
Quickdraw Knotless Soft Tissue Fixation System and the Ortholoc 3Di
Ankle Fracture System. The two offerings will be sold in certain
ex-U.S. countries via Wright Medical Group’s distributor-based as
well as direct sales force. These offerings will be immediately
available in the domestic market thanks to the company’s dedicated
foot and ankle sales team.
Quickdraw Soft Tissue Fixation System, which is based on
Arthocare’s prominent Opus knotless suturing know-how, is a
solution for a number of soft tissue re-joining procedures
pertaining to the foot and ankle. Such procedures number more than
a quarter of a million every year in the U.S. The system is
comprised of the Mini-Belay and Belay knotless suture anchors and
Rappel-line surgical suture and instrumentation, which is intended
to safely and rapidly fixate broken or reattach tendons in the
ankle and foot, including the restoration of the Achilles
tendon.
The Ortholoc 3Di Ankle Fracture System is a complete
solitary-tray ankle fracture offering intended to tackle a wide
array of fractures. It utilizes the Ortholoc 3Di polyaxial locking
know-how, which has features that allow the surgeon to match the
ideal implant with the type of fracture. This ability can cut down
on complications in the operation theater. Fractured ankles are a
common foot injury and about 170,000 such injuries are surgically
treated each year.
In a major move, Wright Medical recently announced that it is
exercising a cost restructuring initiative to improve
profitability, promote growth and strengthen cash flow, leading to
enhanced shareholder value. The restructuring initiative will lead
to a more cost efficient enterprise, which will boost earnings in
2012.
As per the plan, Wright Medical has launched several measures to
curtail expenditure, including cutting down the range of its
overseas product offerings, streamlining its R&D efforts, fine
tuning factory operations and reducing headcount.
Want more from Zacks Equity Research? Subscribe to the free
Profit from the Pros newsletter: http://at.zacks.com/?id=5515.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and
qualitative analysis to help investors know what stocks to buy and
which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly
traded stocks. Our analysts are organized by industry which gives
them keen insights to developments that affect company profits and
stock performance. Recommendations and target prices are six-month
time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides
highlights of the latest analysis from Zacks Equity Research.
Subscribe to this free newsletter today:
http://at.zacks.com/?id=5517
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc.,
which was formed in 1978 by Leon Zacks. As a PhD from MIT Len knew
he could find patterns in stock market data that would lead to
superior investment results. Amongst his many accomplishments was
the formation of his proprietary stock picking system; the Zacks
Rank, which continues to outperform the market by nearly a 3 to 1
margin. The best way to unlock the profitable stock recommendations
and market insights of Zacks Investment Research is through our
free daily email newsletter; Profit from the Pros. In short, it's
your steady flow of Profitable ideas GUARANTEED to be worth your
time! Register for your free subscription to Profit from the Pros
at http://at.zacks.com/?id=5518.
Visit http://www.zacks.com/performance for information about the
performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook:
http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results.
Investors should always research companies and securities before
making any investments. Nothing herein should be construed as an
offer or solicitation to buy or sell any security.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
AETNA INC-NEW (AET): Free Stock Analysis Report
CIGNA CORP (CI): Free Stock Analysis Report
UNITEDHEALTH GP (UNH): Free Stock Analysis Report
WELLPOINT INC (WLP): Free Stock Analysis Report
WRIGHT MEDICAL (WMGI): Free Stock Analysis Report
To read this article on Zacks.com click here.
Aetna (NYSE:AET)
Historical Stock Chart
From Apr 2024 to May 2024
Aetna (NYSE:AET)
Historical Stock Chart
From May 2023 to May 2024